share_log

Piper Sandler Maintains Overweight on InspireMD, Raises Price Target to $4.5

Benzinga ·  Nov 3, 2023 03:58

Piper Sandler analyst Adam Maeder maintains InspireMD (NASDAQ:NSPR) with a Overweight and raises the price target from $3.5 to $4.5.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment